Abpro Holdings ABPO
OTC ABPO
$0.19 -0.02 (-11.26%)
As of: Aug 21, 2026 · 3:37 PM EDT

Abpro Holdings (ABPO) Net Cash Flow (2022 - 2026)

Abpro Holdings' (ABPO) quarterly Net Cash Flow came in at $5.3 million in Q1 2026, up 435.92% YoY from $994743.9 in Q1 2025, and up 2142.53% on a QoQ basis from -$261000.0 in Q4 2025.

Abpro Holdings (ABPO) Net Cash Flow (2022 - 2026) Analysis & Trends

Abpro Holdings (ABPO) has 5 years of Net Cash Flow data on file, last reported at $5.3 million in Q1 2026.

  • Quarterly Net Cash Flow rose 435.92% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 299.4% YoY) and the FY2025 annual result came in at -$2.9 million, down 237.78% from the prior year.
  • Net Cash Flow rose to $5.3 million in Q1 2026, from -$261000.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $271.3 million in Q4 2023 to a low of -$1.7 million in Q3 2025.
  • A 5-year average of $18.0 million and a median of -$35541.0 in 2022 frame the typical range for Net Cash Flow.
  • Annual changes were most pronounced in 2023 — Net Cash Flow soared 133289.88% — and 2025, when it tumbled 2013.58%.
  • Tracing ABPO's Net Cash Flow over 5 years: stood at $203415.0 in 2022, then soared by 133289.88% to $271.3 million in 2023, then tumbled by 98.95% to $2.9 million in 2024, then slumped by 109.15% to -$261000.0 in 2025, then soared by 2142.53% to $5.3 million in 2026.
  • The last three Net Cash Flow figures came in at $5.3 million (Q1 2026), -$261000.0 (Q4 2025), and -$1.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -183.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 407.41 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -496,000.00
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -2.83 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -37.14 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 225.59 Mn
10 Abpro Holdings 1.14 Mn 1.14 Mn - -1.18 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.33 Mn
Mar 31, 2026 5.33 Mn
Dec 31, 2025 -261,000.00
Dec 31, 2025 -261,000.00
Sep 30, 2025 -1.71 Mn
Sep 30, 2025 -1.71 Mn
Jun 30, 2025 624,000.00
Jun 30, 2025 624,000.00
Mar 31, 2025 -1.59 Mn
Mar 31, 2025 -1.59 Mn
Dec 31, 2024 2.85 Mn
Dec 31, 2024 2.85 Mn
Sep 30, 2024 -81,000.00
Sep 30, 2024 -81,000.00
Jun 30, 2024 -186,000.00
Jun 30, 2024 -186,000.00
Mar 31, 2024 29.19 Mn
Mar 31, 2024 29.19 Mn
Dec 31, 2023 271.34 Mn
Dec 31, 2023 271.34 Mn